Compare Heron Therapeutics Inc (HRTX) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Roblox Corp — how do they compare? Heron Therapeutics Inc trades at $0.4 (market cap $68.01M), while Roblox Corp trades at $48.76 (market cap $32.52B). The key difference: Roblox Corp is far larger — about 478.2× Heron Therapeutics Inc's market cap, and Roblox Corp is more actively traded (14,552,045 versus 1,891,941). Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Roblox Corp for 93 Days on average.
| HRTX | RBLX | |
|---|---|---|
Market Cap | $68.01M | $32.52B |
Volume | 1,891,941 | 14,552,045 |
Sector | Health | Technology |
52-Week High | $1.49 | $138.56 |
52-Week Low | $0.27 | $35.54 |
Typical Hold Time | 35 Days | 93 Days |
Enterprise Value | $174.75M | $31.34B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
Roblox (RBLX) trades at $46.41, up 1.87% with bullish technical indicators and strong support at $45. The company shows impressive revenue growth from $2.2B in 2022 to $4.89B in 2025, though it remains unprofitable with a -17.61% net margin. Recent earnings have consistently beaten expectations, and operating cash flow improved significantly to $1.8B in 2025.
While analyst sentiment is mixed with 42% buy ratings, the consensus price target of $50.85 suggests 9.6% upside potential. Key risks include persistent losses, high P/B ratio of 213.94, and recent Jefferies downgrade citing bookings concerns. The stock's trajectory depends on continued user growth and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
